Molecular Analysis of Factor V Leiden,Factor V Hong Kong,Factor II G20210A,Methylenetetrahydrofolate Reductase C677T,and A1298C Mutations Related to Turkish Thrombosis Patients

Abstract

Inherited gene disorders related to the hemostatic system have been documented as risk factors for thrombosis. The roles of factor V Hong Kong (FV Hong Kong), factor V Leiden (FV Leiden), factor II G20210A (FII G20210A), methylenetetrahydrofolate reductase (MTHFR) C677T, and MTHFR A1298C mutations in Turkish patients with thrombosis (270 patients) compared with healthy controls (114 subjects) were evaluated. Polymerase chain reaction—based restriction enzyme analysis was carried out to screen these mutations, and single-strand conformation analysis was established to identify variations using the primers selected for restriction enzyme analysis studies. As a result, a significant relationship was determined among FV Leiden, FII G20210A, and thrombosis. The FV Hong Kong mutation was observed in only 2 patients with pulmonary vein thrombosis who are FV Leiden/FV Hong Kong compound heterozygous for FV gene. MTHFR C677T and A1298C were equally distributed in the patient group compared with the control group. All named mutations were also identified with single-strand conformation analysis, but a new variant/polymorphism during studies was not found. Because some inherited abnormalities are associated with thromboembolic disorders, determining the mutations and gene-to-gene interactions in patients with thrombosis history has a great impact on diagnosis and treatment of these diseases.

Keywords

Deep vein thrombosis Inherited coagulation factor Mutation Turkish population.

References

Handin RI Disorders of coagulation and thrombosis. In: Braunwals E , Fauci AS , Kasper DL , et al, eds. Harrison's Principles of Internal Medicine New York, NY: McGraw-Hill; 2001:751.

Gerhardt A. , Scharf RE , Beckman MW , et al. Prothrombin and factor V mutations in women with history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374-380.

Tirado I. , Mateo J. , Soria JM , et al. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Haemotologica. 2001;86:1200-1208.

Chango A. , Boisson F. , Barbe F. , et al. The effect of 677 C to T and 1298 A to C mutations on plasma homocysteine and 5,10-metylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 2000;83:593-596.

Poort SR , Rosendaal FR , Bertina RM A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.

Chan WP , Lee CK , Kwong YL , et al. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese . Blood. 1998;91:1135-1139.

Rosendaal FR , Koster T. , Vanderbroucke JP , et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.

Soria JM , Almasy L. , Souto JC , et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood. 2000;95:2780-2785.

Kang SS , Passen EL , Ruggie N. , et al. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993 ;88:1463-1469.

10.

Miller M. , Dykes DD , Polesky HF A simple salting out procedure for extracting DNA from human nucleate cells . Nucleic Acids Res. 1988;16:1215-121.

11.

Gurgey A. , Haznedaroglu IC , Egesel T. , et al. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol. 2001;67:107-111.

12.

Varela MI , Adamczuk YP , Forastiero RR , et al. Major and potential prothrombotic genotypes in a cohort of patient with venous thromboembolism. Thromb Res. 2001 ; 104:317.

13.

Grossman R. , Schwender S. , Geisen U. , et al. CBS 844 ins68, MTHFR TT677 and EPCR 4031 ins 23 genotypes in patients with deep-vein thrombosis. Thromb Res. 2002; 107:13-15.

14.

Lu Y. , Zhao Y. , Liu G. , et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation and MTHFR C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7-12.

15.

Ordonez Ajg , Carreira Jmf , Alvarez Crf , et al. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A. Thromb Haemost. 2000;83:352-354.

16.

Schafer AI , Levine MN , Konkle BA , et al. Thrombotic disorders: diagnosis and treatment. Am Soc Hematol. 2003;520.

17.

Murrin S. , Marelich GP , Arroliga AC , et al. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med. 1998;158:1369-1373.